press-category

press-category

CAESAREA, Israel and TAMPA, Fla., Aug. 1, 2017 /PRNewswire/ -- Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients undergoing cardiac procedures, today announced plans to initiate clinical trials for a new, advanced version of Keystone Heart TriGuard™ cerebral embolic protection device.  This third-generation...

CAESAREA, Israel and TAMPA, Fla. and HANGZHOU, China, March 2, 2017 /PRNewswire/ -- Keystone Heart Ltd., a medical device company focused on developing cerebral embolic protection devices for patients undergoing cardiac procedures, and Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced a partnership agreement to provide Venus...

CAESAREA, Israel, und TAMPA, Florida, und HANGZHOU, China, 2. März 2017 /PRNewswire/ -- Keystone Heart Ltd., ein Medizinprodukteunternehmen, das auf die Entwicklung von Hirnembolie-Schutzsystemen für Herzeingriffe spezialisiert ist, und Venus Medtech (Hangzhou) Inc., der führende chinesische Anbieter von Transkatether-Herzklappen, haben heute einen Kooperationsvertrag verkündet, um das TAVR-System von...

Keystone Heart and Venus MedTech Announce Partnership for Cerebral Embolic Protection with Transcatheter Heart Valve Systems (TAVR) in China and Key Asian Markets   This First Comes on Heels of New Published Guidelines Pointing To Need for Cerebral Protection During TAVR   CAESAREA, Israel, TAMPA, Florida and HANGZHOU, China, — March 2, 2017— Keystone...

CAESAREA, Israel and TAMPA, Fla., Feb. 27, 2017 /PRNewswire/ -- Keystone Heart Ltd., an emerging medical device company focused on developing cerebral embolic protection devices for patients undergoing cardiac procedures, applauds the members of the FDA's Circulatory System Devices Panel that convened this past week for their acknowledgement of...